Stay updated on Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial page.

Latest updates to the Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial page
- Check2 days agoChange DetectedThe page history now shows an addition of Revision: v3.4.1 and removal of Revision: v3.4.0, reflecting a minor update to the record’s version history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check9 days agoChange DetectedUI updates add a Show glossary option, green and red highlights to indicate additions and deletions, and a Revision: v3.4.0, with No FEAR Act data removal noted (v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision: v3.3.4 was added to the record history. Revision: v3.3.3 was removed.SummaryDifference0.1%

- Check45 days agoChange DetectedThe history now includes Revision: v3.3.3, and the HHS Vulnerability Disclosure and Revision: v3.3.2 entries were removed.SummaryDifference0.2%

- Check59 days agoChange DetectedThe record history now includes core results-related sections such as Results Posted, Outcome Measures (Results), Adverse Events, Baseline Characteristics, and Participant Flow, along with More Information and Limitations and Caveats; the previous entry 'Results Submitted' appears to be removed.SummaryDifference1%

- Check74 days agoChange DetectedA new revision entry v3.3.2 was added to the Record History, replacing the previous v3.2.0. No substantive changes to the study information are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial page.